Chinese expert consensus on biomarkers for heart failure / 中华检验医学杂志

ABSTRACT

Themorbidity and mortality of heart failure (HF) are increasing with the rise of life expectancy in recent years, which emphasize the early diagnosis and optimal treatment. Biomarkers for HF play an important role in the prediction, diagnosis, prognosis and treatment guiding of HF. Natriuretic peptide (NP) is the most widely used biomarkers for HF. However, NP is not an ideal biomarker due to low specificity. Recently, more biomarkers were found to be valuable on the basis of NP in the evaluation of HF. This consensus summarized the biomarkers for HF according to latest clinical guidelines, expert statements and clinical trials. It is meant to provide reference in the application ofbiomarkers for HF.